Sangamo Therapeutics
SGMO
SGMO
148 hedge funds and large institutions have $820M invested in Sangamo Therapeutics in 2017 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 54 increasing their positions, 38 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
26% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 23
3% more funds holding
Funds holding: 143 → 148 (+5)
8.36% less ownership
Funds ownership: 73.73% → 65.37% (-8.4%)
Holders
148
Holding in Top 10
5
Calls
$21.1M
Puts
$15.8M
Top Buyers
| 1 | +$19.9M | |
| 2 | +$18.5M | |
| 3 | +$16.6M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$15.3M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$13.2M |
Top Sellers
| 1 | -$35.2M | |
| 2 | -$30M | |
| 3 | -$26.1M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$14.7M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$12M |